Molecular mechanisms for enhanced DNA vaccine immunogenicity
L Li, N Petrovsky - Expert review of vaccines, 2016 - Taylor & Francis
In the two decades since their initial discovery, DNA vaccines technologies have come a
long way. Unfortunately, when applied to human subjects inadequate immunogenicity is still …
long way. Unfortunately, when applied to human subjects inadequate immunogenicity is still …
DNA vaccination for finfish aquaculture
C Collins, N Lorenzen, B Collet - Fish & shellfish immunology, 2019 - Elsevier
In fish, DNA vaccines have been shown to give very high protection in experimental facilities
against a number of viral diseases, particularly diseases caused by rhabdoviruses …
against a number of viral diseases, particularly diseases caused by rhabdoviruses …
Targeted delivery of nanovaccine to dendritic cells via DC-binding peptides induces potent antiviral immunity in vivo
Y Lu, ZH Liu, YX Li, HL Xu, WH Fang… - International Journal of …, 2022 - Taylor & Francis
Background Dendritic cell (DC) targeted antigen delivery is a promising strategy to enhance
vaccine efficacy and delivery of therapeutics. Self-assembling peptide-based nanoparticles …
vaccine efficacy and delivery of therapeutics. Self-assembling peptide-based nanoparticles …
Targeting the central nervous system (CNS): a review of rabies virus-targeting strategies
M Oswald, S Geissler, A Goepferich - Molecular pharmaceutics, 2017 - ACS Publications
The transport of drugs across the blood–brain barrier is challenging. The use of peptide
sequences derived from viruses with a central nervous system (CNS) tropism is one elegant …
sequences derived from viruses with a central nervous system (CNS) tropism is one elegant …
DNA vaccines for prostate cancer
CD Zahm, VT Colluru, DG McNeel - Pharmacology & therapeutics, 2017 - Elsevier
DNA vaccines offer many advantages over other anti-tumor vaccine approaches due to their
simplicity, ease of manufacturing, and safety. Results from several clinical trials in patients …
simplicity, ease of manufacturing, and safety. Results from several clinical trials in patients …
Dendritic cells/macrophages-targeting feature of Ebola glycoprotein and its potential as immunological facilitator for antiviral vaccine approach
In the prevention of epidemic and pandemic viral infection, the use of the antiviral vaccine
has been the most successful biotechnological and biomedical approach. In recent times …
has been the most successful biotechnological and biomedical approach. In recent times …
Enhanced contraception of canine zona pellucida 3 DNA vaccine via targeting DEC-205 in mice
Y Wang, B Zhang, J Li, A Aipire, Y Li, F Zhang - Theriogenology, 2018 - Elsevier
Abstract Zona pellucida 3 (ZP3) is a potential antigen for the development of contraceptive
vaccines to control animal population. In this study, we designed a canine ZP3 (CZP3) DNA …
vaccines to control animal population. In this study, we designed a canine ZP3 (CZP3) DNA …
Enhanced delivery of Mycobacterium tuberculosis antigens to antigen presenting cells using RVG peptide
O Garnica, K Das, S Devasundaram… - Tuberculosis, 2019 - Elsevier
Among the various strategies to improve vaccines against infectious diseases, targeting of
antigens to dendritic cells (DCs), which are professional antigen presenting cells (APCs) …
antigens to dendritic cells (DCs), which are professional antigen presenting cells (APCs) …
Development and characterization of a novel DC-targeting universal influenza vaccine
T Olukitibi - 2024 - mspace.lib.umanitoba.ca
The highly contagious pandemic potential influenza virus causes around 650,000 annual
deaths despite available vaccines. Developing a universal influenza vaccine is crucial for …
deaths despite available vaccines. Developing a universal influenza vaccine is crucial for …
Targeted-delivery of small interference rna against anthrax
M Zeng - 2016 - Google Patents
WO2016205331A1 - Targeted-delivery of small interference rna against anthrax - Google
Patents WO2016205331A1 - Targeted-delivery of small interference rna against anthrax …
Patents WO2016205331A1 - Targeted-delivery of small interference rna against anthrax …